GlassScriptPhysician profile
Christine Booth
NPI 1790844256
$3,585.91
in general payments reported to CMS, 2019-2025
40 companies · $684 in 2025
The $684 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $328 · 2021: $584 · 2022: $491 · 2023: $429 · 2024: $574 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,687.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $394.49 | 2019-2024 | Injectafer |
| Biogen, INC. | $279.69 | 2025 | Zurzuvae |
| Pfizer INC. | $263.67 | 2019-2024 | |
| Exeltis, USA INC. | $262.66 | 2019-2025 | Slynd |
| Shield Therapeutics INC | $230.06 | 2022-2025 | Accrufer |
| Abbvie INC. | $224.63 | 2019-2023 | Liletta |
| Coopersurgical, INC. | $189.77 | 2020-2025 | Paragard T 380a, Paragard T 380a, Endosee |
| Bayer Healthcare Pharmaceuticals INC. | $167.18 | 2019-2025 | |
| Exact Sciences Corporation | $148.46 | 2023-2025 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $138.51 | 2021-2022 | |
| Organon LLC | $124.90 | 2021-2025 | Nexplanon |
| Novo Nordisk INC | $116.58 | 2019-2023 | |
| Astellas Pharma US INC | $116.43 | 2024-2025 | Veozah |
| Agile Therapeutics, INC. | $111.55 | 2021-2024 | Twirla |
| Dexcom, INC. | $98.38 | 2023-2025 | Dexcom G6 Transmitter |
Show all 39 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Booth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.